Welcome to Orlando

Welcome to Orlando

The Hebrew word for it is hrh. The Hindus speak of prabodhan. In Chinese, it’s qishi. The teachings of Buddhism discuss bodhi ... keihatsu in Japanese. The French use eclaircissement. In my native language, Urdu, it is agahi. In English, the term is enlightenment — an...

Trainees Strengthen Their Drive for Hematology at ASH-a-Palooza!

Trainees Strengthen Their Drive for Hematology at ASH-a-Palooza!

My first question was critical: What kind of gifts will ASH-a-Palooza bear this year? Formerly known as “Trainee Day,” the now reinvented ASH-a-Palooza was a half-day, interactive tour de force of learning, networking, and mentorship. There were also, of course,...

Mission (Im)Possible

The year 1982 heralds the discovery of the first mutated genes to be identified in cancer, RAS. The three RAS genes — KRAS, NRAS, and HRAS — still constitute the most frequently mutated oncogene family in human cancers. However, despite more than three decades of...

Oh, How Far We’ve Come!

Since I was little, I’ve been surrounded by scientific intrigue. One of my first memories of the idea of moving genetic material into a person was from my early high school days. When discussing gene transfer, a classmate asked, “So, we could make people blue by...

Saturday’s Continuing Conversations With the Speakers

Continuing Conversations With the Speakers sessions allow for informal discussions with Scientific Program session speakers that will give interested individuals, especially trainees and junior investigators, increased accessibility both to information on the topic...

A Quantum Leap in Myeloma Therapy

More than a century ago, the brilliant physicist Max Planck investigated an obscure subject and sparked a revolution in physics. A profoundly conservative thinker, Planck had to disavow some orthodox theoretical ideas to assume that the total energy of all atoms at...

Blood Welcomes New Editions to the International Roster

After the uniquely positive experiences following the launch of the initial local language editions of Blood in Italy, Spain, and Latin America, we are delighted to announce that two new editions are being added to the international family of journals: Chinese Blood...

Lymphoma Roundup: Verdict on This Year’s Annual Meeting

Since Thomas Hodgkin’s initial characterization of lymphomas in 1832 and the first administration of mustard to a patient with lymphoma 100 years later amid the secrecy of a World War II gas program, much has changed. Multiple recurrent themes characterize the...

Invisible Warriors

In the social media community of patients with sickle cell disease (SCD) and their advocates, the moniker of “sickle cell warrior” has been widely adopted to unify those who struggle daily with the burden of this relentless disease. Yet, for far too many of them,...

Spotlight on Global Capacity Building

The Global Capacity-Building Showcase (Hall B, Level 2 [Orange County Convention Center] - map it ) is an annual meeting poster category designed to encourage international collaborations in the form of capacity-building programs in low- and middle-income countries....

Update on Precision Medicine Initiatives

Applying the principles of precision medicine to hematologic diseases is a priority for ASH. Precision medicine encompasses all approaches that use patient- and disease-specific information to prevent, diagnose, and treat a disease. The increasingly widespread use of...

Special Sessions Offer Inside Look at Peer Review

This year’s meeting will offer two Special-Interest Sessions tailored for all those who have an interest in learning more about both sides of the peer review process. First Editor-in-Chief of Blood Bob Löwenberg, MD, PhD, will lead the discussion “How to Get Published...

ASH Clinical Practice Guidelines Update

ASH has long recognized the need for comprehensive guidelines and in the past three years has broken ground on developing and/or updating guidelines on several disease types, including venous thromboembolism (VTE), immune thrombocytopenia (ITP), acute myeloid leukemia...

Update on ASH Immunotherapies Initiatives

The field of immunotherapy has generated novel immune-based strategies and improved the utility of existing treatment options for various hematologic diseases. As such, ASH has had an enduring interest in improving immunotherapies for all hematologic diseases. This is...

ASH Research Collaborative Data Hub

The Data Hub, a component of the recently launched ASH Research Collaborative (ASH RC), is a technology platform that facilitates the exchange of information by aggregating research-grade data on hematologic diseases in one place and making it available for inquiry....

National Partner Society Abstract Achievement Awards

The National Partner Society Abstract Achievement Awards consist of a $2,000 grant awarded to an international hematologist, who must be a member of the supporting organization and resident of the respective country, to help advance knowledge and inspire continued...

ASH Congratulates the 2019 MRHAP Winners

In 2018 ASH announced an entirely new program for under-represented minority residents, the ASH Minority Resident Hematology Award Program (MRHAP), the goal of which is to provide support for under-represented minority residents to conduct hematology-focused research...

ASH Congratulates the 2019 MMSAP Participants

ASH Congratulates the 2019 MMSAP Participants

Since 2004, the ASH Minority Medical Student Award Program (MMSAP) has provided under-represented minority medical students with an opportunity to engage in an eight-to-12-week hematology-related research project under the guidance of an ASH member. In 2016 the...

ASH Newborn Screening Initiative and Consortium

In an effort to raise awareness of sickle cell disease (SCD) globally by partnering with international organizations to expand SCD-focused education, ASH is exploring the development of a Consortium of African countries to address newborn screening for SCD. The...

A One-of-a-Kind “How I Treat” Experience

Hearing the words “How I Treat” might stir up a diverse array of concepts for hematologists. It can refer to both the popular compendium series of Blood articles as well as the format of talks given at the ASH Meeting on Hematologic Malignancies, but it is always...

With Diversity As a Priority, Everyone Wins

With Diversity As a Priority, Everyone Wins

Griffin Rodgers, MD, of the National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) is awarded the 2019 ASH Award for Leadership in Promoting Diversity. Dr. Rodgers earned the prestigious recognition for his ongoing work on behalf of under-represented...

How to Equip Yourself for Advocacy

How to Equip Yourself for Advocacy

If you are plugged into ASH member communications such as NewsLink or the “Headlines From Washington” column in The Hematologist, you know that your U.S. colleagues are always keeping busy on the advocacy front. For years ASH has been at the foreground of influencing...

Share This